YiFan Pharmaceutical Co.,Ltd.

China

Back to Profile
1-1 of 1 for YiFan Pharmaceutical Co.,Ltd. Sort by
Query
Aggregations
IPC Class
A61K 33/36 - ArsenicCompounds thereof 1
A61K 36/19 - Acanthaceae (Acanthus family) 1
A61K 36/315 - Isatis, e.g. Dyer's woad 1
A61K 36/36 - Caryophyllaceae (Pink family), e.g. babysbreath or soapwort 1
A61K 36/537 - Salvia (sage) 1
See more
Found results for  patents

1.

MEDICINE COMPOSITION FOR TREATING LEUKEMIA AND PREPARATION METHOD THEREFOR

      
Application Number CN2016078911
Publication Number 2017/101236
Status In Force
Filing Date 2016-04-08
Publication Date 2017-06-22
Owner
  • YI FAN PHARMACEUTICAL ACADEMY (BEIJING) CO., LTD. (China)
  • YIFAN PHARMACEUTICAL CO., LTD. (China)
Inventor
  • Cheng, Xianfeng
  • Zhou, Wenyan
  • Liang, Xiaodong
  • Qian, Liping

Abstract

A Medicine composition for treating leukemia, mainly prepared from, by weight, 2-8% of realgar, 25-42% of indigo naturalis, 50-60% of salviae miltiorrhizae and 6-10% of radix pseudostellariae. The invention improves the preparation method for salviae miltiorrhizae, reduces the amount of added water, the times of decoction and the decoction time. The extraction rate of tanshinone IIA reaches 75%. The medicine composition provided by the invention can be used for treating leukemia, having a complete remission rate of 92.9%, improved curative effect, and reduced toxic and side effect.

IPC Classes  ?